OpenVSafe by OpenVAERS
Search V-safe

5XV-30499-90335

2 vaccinations 5 coded responses 14 check-ins 5 free-text entries 2 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
895 / NV
Registered
2021-01-13
Relationship
Self
Race
Multiracial
Ethnicity
N/A

Timeline

  1. 2021-01-13
    Registered in v-safe
  2. 2021-01-13
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-13
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-01-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Abdominal pain
    Adult check-in
  6. 2021-01-27
    Survey response — day 14, dose 1
    MedDRA: Nasopharyngitis, Respiratory tract congestion, Sinus headache — Feeling: Good
    Free text: Cold like symptoms... sinus headache and congestion.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-02-03
    Dose 2 — Pfizer-BioNTech
  8. 2021-02-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: Palpitations — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work
    Free text: Heart palpitations (PVCs and PACs)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  10. 2021-02-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · None
    Adult check-in
  11. 2021-02-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fever · None
    Adult check-in
  12. 2021-02-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · None
    Adult check-in
  13. 2021-02-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-17
    Survey response — day 14, dose 2
    MedDRA: Hypertension — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Consistently high blood pressure
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-26
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-03-10
    Survey response — day 35, dose 2
    MedDRA: Blood pressure increased, C-reactive protein increased, Dyspnoea, Inflammation, Red blood cell sedimentation rate increased, Skin discolouration — Feeling: Fair · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Elevated CRP and Sedimentation Rate with raised inflammation. Was referred to Rheumatology for a possible new autoimmune disease. Shortness of breath and blood pressure increased. Dark patches in arm pits.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-03-10
    Report sent to call center — day 35, dose 2
    Be unable to work · Get care from a doctor or other healthcare professional
    1 call case(s)
  18. 2021-03-19
    Survey response — day 42, dose 2
    MedDRA: Blood test abnormal, C-reactive protein abnormal, Condition aggravated, Inflammation, Pre-existing disease, Red blood cell sedimentation rate abnormal — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Worsening high blood pressure. High inflammation discovered by recent blood test, with no indication of infection. Afnormal CRP and Westergren Sed Rate results.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-03-19
    Report sent to call center — day 42, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-10-26

Vaccinations

DoseDateManufacturerCo-administered
12021-01-13Pfizer-BioNTech
22021-02-03Pfizer-BioNTech

Call center

2 call center cases

2 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 2 — day 14, dose 1

2021-01-27

Symptoms: Cold like symptoms... sinus headache and congestion.

Release 3 — days 1–6 daily, dose 2

2021-02-04

Systemic reaction (other): Heart palpitations (PVCs and PACs)

Release 4 — day 14, dose 2

2021-02-17

Symptoms: Consistently high blood pressure

Release 5 — day 35, dose 2

2021-03-10

Symptoms: Elevated CRP and Sedimentation Rate with raised inflammation. Was referred to Rheumatology for a possible new autoimmune disease. Shortness of breath and blood pressure increased. Dark patches in arm pits.

Release 6 — day 42, dose 2

2021-03-19

Symptoms: Worsening high blood pressure. High inflammation discovered by recent blood test, with no indication of infection. Afnormal CRP and Westergren Sed Rate results.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBlood pressure increased ✓ ✓ ✓
SDBlood test abnormal ✓ ✓ ✓
SDC-reactive protein abnormal ✓ ✓ ✓
SDC-reactive protein increased ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDHypertension ✓ ✓ ✓
SDInflammation ✓ ✓ ✓
SDNasopharyngitis ✓ ✓ ✓
SDPre-existing disease ✓ ✓ ✓
SDRed blood cell sedimentation rate abnormal ✓ ✓ ✓
SDRed blood cell sedimentation rate increased ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDSinus headache ✓ ✓ ✓
SDSkin discolouration ✓ ✓ ✓
SROPalpitations ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release